CapsoVision has taken a key regulatory step toward expanding the role of AI in capsule endoscopy. The company announced the submission of an FDA 510(k) application for an AI-assisted reading module designed to enhance pathology detection and reduce clinician review time for its CapsoCam Plus system. Framed as part of a broader push toward cloud-based, AI-enabled GI diagnostics, the move highlights how capsule endoscopy platforms are evolving beyond image capture alone. Whether this approach meaningfully reshapes small-bowel workflows—and how it compares with existing solutions—becomes clearer in the full announcement from CapsoVision.
Trending
- Top 10 ASC News Stories of 2025 (ASC News)
- Remote Patient Monitoring and Connected Technologies in Inflammatory Bowel Disease (GI & Hepatology)
- How physicians can negotiate work relative value unit contracts with large health systems (Healio)
- Large VA QI Program Finds CADe Benefit Durable (GI & Endoscopy News)
- CMS kicks off GLP-1 model: 7 notes (Becker’s GI & Endoscopy)
- ‘Pleasantly surprised’: Subcutaneous infliximab effective, regardless of Crohn’s location (Healio)
- Gastroenterology Career Insights: Trends, Tech, and What Employers Are Looking For in 2026 (AMN Healthcare)
- 5 GIs who stepped into leadership roles in 2025 (Becker’s GI & Endoscopy)
